The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.
Richard B. Hancock net worth and biography

Richard Hancock Biography and Net Worth

Director of Avid Bioservices
Mr. Hancock was appointed to the Board of Directors in November 2017 and served as our interim President and Chief Executive Officer from May 2019 to July 2020. Mr. Hancock has worked in the biologic CDMO industry for over 30 years in various operational and executive roles, serving most recently as President and Chief Executive Officer of Althea Technologies, Inc., a large molecule CDMO producing a wide range of biologics, vaccines and parenteral products. In addition to Althea, Mr. Hancock has held senior management positions at The Immune Response Corporation, and Hybritech Inc. (now part of Eli Lilly & Company), and he is currently the Chairman of the Board and Executive Director of Argonaut Manufacturing Services, Inc., a privately-owned CDMO focused on the biotechnology and life sciences industries. He also serves on the Board of Directors of Tempo Therapeutics, a privately-held company, focused on cell therapy, vaccine technology, and complex wounds. Mr. Hancock received a B.A. in Microbiology from Miami University. 

What is Richard B. Hancock's net worth?

The estimated net worth of Richard B. Hancock is at least $641,406.26 as of January 12th, 2023. Mr. Hancock owns 39,134 shares of Avid Bioservices stock worth more than $641,406 as of January 29th. This net worth approximation does not reflect any other assets that Mr. Hancock may own. Learn More about Richard B. Hancock's net worth.

What is Richard B. Hancock's salary?

As the Director of Avid Bioservices, Inc., Mr. Hancock earned a total compensation package of $926,201.00 in 2021. Mr. Hancock earned a salary of $148,923.00, a bonus of $123,730.00, stock awards of $194,982.00, options awards of $455,084.00, and other compensation of $3,509.00. Learn More on Richard B. Hancock's salary.

How do I contact Richard B. Hancock?

The corporate mailing address for Mr. Hancock and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected] Learn More on Richard B. Hancock's contact information.

Has Richard B. Hancock been buying or selling shares of Avid Bioservices?

During the past quarter, Richard B. Hancock has sold $80,000.00 of Avid Bioservices stock. Most recently, Richard B. Hancock sold 5,000 shares of the business's stock in a transaction on Thursday, January 12th. The shares were sold at an average price of $16.00, for a transaction totalling $80,000.00. Following the completion of the sale, the director now directly owns 39,134 shares of the company's stock, valued at $626,144. Learn More on Richard B. Hancock's trading history.

Who are Avid Bioservices' active insiders?

Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.

Are insiders buying or selling shares of Avid Bioservices?

In the last twelve months, insiders at the biopharmaceutical company sold shares 26 times. They sold a total of 141,438 shares worth more than $2,537,973.45. The most recent insider tranaction occured on January, 12th when Director Richard B Hancock sold 5,000 shares worth more than $80,000.00. Insiders at Avid Bioservices own 1.9% of the company. Learn More about insider trades at Avid Bioservices.

Information on this page was last updated on 1/12/2023.

Richard B. Hancock Insider Trading History at Avid Bioservices

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2023Sell5,000$16.00$80,000.0039,134View SEC Filing Icon  
12/2/2022Sell10,000$16.11$161,100.0036,881View SEC Filing Icon  
10/3/2022Sell5,000$18.43$92,150.0036,881View SEC Filing Icon  
8/1/2022Sell5,000$19.40$97,000.0037,215View SEC Filing Icon  
7/5/2022Sell5,000$16.03$80,150.0035,201View SEC Filing Icon  
6/27/2022Sell7,537$16.07$121,119.5935,201View SEC Filing Icon  
6/24/2022Sell2,463$16.02$39,457.2638,936View SEC Filing Icon  
4/1/2022Sell5,000$21.21$106,050.0035,200View SEC Filing Icon  
3/1/2022Sell5,000$19.86$99,300.00View SEC Filing Icon  
2/1/2022Sell5,000$18.81$94,050.00View SEC Filing Icon  
1/3/2022Sell5,000$27.53$137,650.00View SEC Filing Icon  
12/1/2021Sell5,000$30.90$154,500.00View SEC Filing Icon  
11/15/2021Sell5,000$32.47$162,350.00View SEC Filing Icon  
3/13/2020Buy12,500$3.99$49,875.0022,500View SEC Filing Icon  
See Full Table

Richard B. Hancock Buying and Selling Activity at Avid Bioservices

This chart shows Richard B Hancock's buying and selling at Avid Bioservices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avid Bioservices Company Overview

Avid Bioservices logo
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Read More

Today's Range

Now: $16.39
Low: $15.91
High: $16.49

50 Day Range

MA: $14.74
Low: $12.61
High: $17.23

2 Week Range

Now: $16.39
Low: $11.30
High: $22.83


416,649 shs

Average Volume

466,566 shs

Market Capitalization

$1.02 billion

P/E Ratio


Dividend Yield



Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.